1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
SEC FILE NUMBER 000-18839
NOTIFICATION OF LATE FILING
(Check One):
CUSIP NUMBER
[X]FORM 10-K AND FORM 10-KSB [ ]FORM 20-F [ ]FORM 11-K
[ ]FORM 10-Q AND FORM 10-QSB [ ]FORM N-SAR
FOR PERIOD ENDED: FOR THE FISCAL YEAR ENDED JUNE 30, 1996
[ ] TRANSITION REPORT ON FORM 10-K
[ ] TRANSITION REPORT ON FORM 20-F
[ ] TRANSITION REPORT ON FORM 11-K
[ ] TRANSITION REPORT ON FORM 10-Q
[ ] TRANSITION REPORT ON FORM N-SAR
FOR THE TRANSITION PERIOD ENDED:_____________________
READ ATTACHED INSTRUCTION SHEET BEFORE PREPARING FORM. PLEASE PRINT OR TYPE.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates: N/A
PART I--REGISTRANT INFORMATION
UNITED AMERICAN HEALTHCARE CORPORATION
- --------------------------------------------------------------------------------
Full Name Of Registrant
1155 Brewery Park Blvd, Suite 200
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
Detroit, MI 48207
- --------------------------------------------------------------------------------
City, State and Zip Code
PART II--RULES 12B-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed. (Check box if appropriate)
[x] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
2
[x] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on
or before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and
[x] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
PART III--NARRATIVE
State below in reasonable detail the reasons why Form 10-K and Form 10-KSB,
20-F, 11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or portion
thereof could not be filed within the prescribed period.
The Registrant has filed for this extension to allow completion of its
audit, which is dependent upon the completion of the audit of its significant
Tennessee subsidiary, OmniCare Health Plan, Inc. and third party financing
for its New York joint venture, United/HealthScope, Inc. on or about October 3,
1996.
PART IV--OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Jagu Vanaharam (313) 393-0200
--------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is
no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
[X] Yes [ ] No
If so: attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
The Registrant expects to report a loss for the year ended June 30, 1996,
as opposed to income reported for the year ended June 30, 1995, the significance
which cannot be measured until completion of the items set forth in Part III
above.
3
UNITED AMERICAN HEALTHCARE CORPORATION
--------------------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date Sept 27, 1996 By /s/ Julius V. Combs
----------------------- ------------------------------------
Julius V. Combs, Chairman and CEO
INSTRUCTION: The form may be signed by an executive officer of the registrant
or by any other duly authorized representative. The name and title of the
person signing the form shall be typed or printed beneath the signature. If
the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).